MATURE B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for MATURE B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for MATURE B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young blood cancer patients: experimental drug glofitamab enters trials
Disease control Recruiting nowThis study tests a drug called glofitamab, alone or with standard chemotherapy, in children and young adults (ages 6 months to under 30) whose B-cell lymphoma has come back or not responded to treatment. The goal is to see if it is safe and can shrink or control the cancer. Parti…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 11:49 UTC
-
New combo therapy aims to boost survival in kids with aggressive lymphoma
Disease control Recruiting nowThis study tests whether giving intensive chemotherapy along with early and strong doses of the targeted drug rituximab can improve outcomes for children and teens with aggressive B-cell non-Hodgkin lymphoma. About 87 participants will receive this combination, and researchers wi…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 20, 2026 11:56 UTC